Neuropathic pain is caused by nervous system disease or injury, and current treatments include antidepressants and anticonvulsants for symptomatic relief.

Neuropathic pain: principles of diagnosis and treatment.

This study proposes a treatment algorithm for neuropathic pain, guiding clinicians to optimize available therapeutic options and streamline referrals to specialized pain clinics for patients truly refractory to traditional pharmacotherapy.

A treatment algorithm for neuropathic pain.

Neuropathic pain can be effectively treated with medications, dosing schedules, and data from randomized controlled trials, even if the underlying cause of neuropathy remains unaddressed.

Treatment of Neuropathic Pain

New treatments like duloxetine hydrochloride and pregabalin show promise in improving diabetic neuropathy symptoms and reducing complications.

Clinical manifestations and current treatment options for diabetic neuropathies.

No consensus on optimal neuropathic pain management exists, and current practices vary greatly worldwide, with diverse treatments including non-invasive drug therapies, invasive therapies, and alternative therapies.

Diagnosis and treatment of neuropathic pain.

First-line treatments for neuropathic pain include SNRIs, gabapentin, topical lidocaine, and transcutaneous electrical nerve stimulation, with psychotherapy recommended as a second-line therapy.

Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.

Diabetic peripheral neuropathy is effectively treated with glucose control and pain management, but new modifiable risk factors are needed for disease-modifying therapies.

Diabetic neuropathy: clinical manifestations and current treatments

Inflammatory neuropathies can be accurately diagnosed and treated, with potential for reversal, and understanding their pathogenesis is crucial for effective treatment and clinical trials.

Diagnosis and treatment in inflammatory neuropathies

A better understanding of the peripheral and central mechanisms causing painful diabetic neuropathy may promote the development of more targeted and effective treatments.

Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.

Spinal cord stimulation, repetitive transcranial magnetic stimulation, and static magnetic field therapy effectively reduce pain in diabetic peripheral neuropathy patients.

Non-Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review

B12 shows some evidence for treating post-herpetic neuralgia and painful peripheral neuropathy.

B12 as a Treatment for Peripheral Neuropathic Pain: A Systematic Review

Neuropathic pain is a result of damage to the somatosensory nervous system, and effective management requires an interdisciplinary approach centered on pharmacological treatment.

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

Pharmacological treatments like tricyclic antidepressants, serotonin noradrenaline reuptake inhibitors, and opioids show limited improvement in neuropathic pain treatment, requiring further large-scale trials to identify patient subgroups.

The evidence for pharmacological treatment of neuropathic pain

Neuropathic pain management requires a multifaceted approach, with pharmacologic agents like tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors being the strongest options, while nonpharmacologic therapies like acupuncture and massage therapy show mixed evidence.

Neuropathic pain

Psychological interventions for chronic neuropathic pain show insufficient evidence of efficacy and safety, with two small studies showing no benefit over waiting list or placebo control groups.

Psychological therapies for the management of chronic neuropathic pain in adults.

Pain management, including pharmacological treatment, positively impacts patients' quality of life in various peripheral neuropathies, with nonpharmacological approaches also beneficial.

Quality of Life in Painful Peripheral Neuropathies: A Systematic Review

Genetic neuropathies can now be accurately diagnosed, with new therapies in development, and research into their pathogenesis has revolutionized our understanding of the peripheral nervous system.

Diagnosis and new treatments in genetic neuropathies

Neuropathic pain is a chronic condition with limited pharmacological treatment options, primarily focusing on symptom control, and polypharmacy may be beneficial in improving quality of life.

Neuropathic Pain and Pharmacological Treatment

Current treatments for neuropathic pain have moderate efficacy and side effects, highlighting the need for new therapeutic approaches.

The neuropathic pain: An overview of the current treatment and future therapeutic approaches

Neuropathic pain (NP) affects 6%-8% of the general population and negatively impacts quality of life, mood, and sleep, but recent redefinitions and guidelines have improved diagnosis and treatment guidelines.

Neuropathic pain: diagnosis and treatment

What is the latest worldwide in research on neuropathies, their treatment and cure? Write me a summa

These studies suggest that neuropathic pain treatments include antidepressants, anticonvulsants, SNRIs, gabapentin, topical lidocaine, and various stimulation therapies, with new treatments like duloxetine and pregabalin showing promise, but there is no consensus on optimal management practices worldwide.